Literature DB >> 2010548

Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

G de Saint-Basile1, F Le Deist, J P de Villartay, N Cerf-Bensussan, O Journet, N Brousse, C Griscelli, A Fischer.   

Abstract

We report the immunological characteristics of five patients with Omenn's syndrome, a rare inherited immunodeficiency also known as combined immunodeficiency with hypereosinophilia. The syndrome is characterized by T cell infiltration of skin, gut, liver, and spleen leading to diffuse erythroderma, protracted diarrhea, failure to thrive, and hepatosplenomegaly. Blood T cells as well as those infiltrating the skin and gut were found to express activation markers and were partially activated by mitogens but not by antigens. Although the lesions resembled those in graft-versus-host disease, the blood T cells were shown by DNA haplotype analysis using probes revealing variable number of tandem repeats to belong to the patients as well as the T cells infiltrating the gut and skin in one patient. A given T cell subset (TCR alpha beta+, CD4+/CD8+, or TCR gamma delta+) was predominant in each patient, with a specific distribution in the skin lesions. Moreover, the study of T cell receptor beta, gamma, and delta gene rearrangements in four patients revealed oligoclonality involving C beta 1, C beta 2, or different V gamma J gamma or V delta J delta genes. This indicates that restricted heterogeneity of the T cell repertoire, previously reported in one case, is a major feature of this syndrome. The occurrence of alymphocytosis-type severe combined immunodeficiency in the brother of one of the patients suggests that the restricted heterogeneity of T cell receptor gene usage in Omenn's syndrome may arise from leakiness, within the context of a genetically determined faulty T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010548      PMCID: PMC295173          DOI: 10.1172/JCI115139

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family.

Authors:  B J Fowlkes; A M Kruisbeek; H Ton-That; M A Weston; J E Coligan; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

2.  Same peculiar subset of HML1 + lymphocytes present within normal intestinal epithelium is associated with tumoral epithelium of gastrointestinal carcinomas.

Authors:  A Jarry; N Cerf-Bensussan; N Brousse; D Guy-Grand; F Muzeau; F Potet
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

3.  Combined immunodeficiency presenting as the Letterer-Siwe syndrome.

Authors:  S D Cederbaum; G Niwayama; E R Stiehm; R C Neerhout; A J Ammann; W Berman
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

4.  Rapidly fatal familial histiocytosis associated with eosinophilia and primary immunological deficiency.

Authors:  R F Barth; G G Vergara; S K Khurana; J T Lowman; J B Beckwith
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

5.  Rearrangements to the JP1, JP and JP2 segments in the human T-cell rearranging gamma gene (TRG gamma) locus.

Authors:  S Huck; M P Lefranc
Journal:  FEBS Lett       Date:  1987-11-30       Impact factor: 4.124

6.  Athymic mice express a high level of functional gamma-chain but greatly reduced levels of alpha- and beta-chain T-cell receptor messages.

Authors:  Y Yoshikai; M D Reis; T W Mak
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

Review 7.  Genetically determined murine models of immunodeficiency.

Authors:  L D Shultz; C L Sidman
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

8.  Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

Authors:  A Fischer; C Griscelli; W Friedrich; B Kubanek; R Levinsky; G Morgan; J Vossen; G Wagemaker; P Landais
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

9.  Evidence of functional lymphocytes in some (leaky) scid mice.

Authors:  G C Bosma; M Fried; R P Custer; A Carroll; D M Gibson; M J Bosma
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  T cell antigen receptor expression in athymic (nu/nu) mice. Evidence for an oligoclonal beta chain repertoire.

Authors:  H R MacDonald; R K Lees; C Bron; B Sordat; G Miescher
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  42 in total

Review 1.  Severe combined immunodeficiency--molecular pathogenesis and diagnosis.

Authors:  H B Gaspar; K C Gilmour; A M Jones
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 2.  Diagnosis of severe combined immunodeficiency.

Authors:  A R Gennery; A J Cant
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 3.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

4.  An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly.

Authors:  J G Ocejo-Vinyals; M J Lozano; P Sánchez-Velasco; J Escribano de Diego; J E Paz-Miguel; F Leyva-Cobián
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

5.  Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

Authors:  Veronica Marrella; Pietro L Poliani; Elena Fontana; Anna Casati; Virginia Maina; Barbara Cassani; Francesca Ficara; Manuela Cominelli; Francesca Schena; Marianna Paulis; Elisabetta Traggiai; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 6.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 7.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

8.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Matched unrelated bone marrow transplant for Omenn syndrome.

Authors:  Amit Nahum; Brenda Reid; Eyal Grunebaum; Chaim M Roifman
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency.

Authors:  Sebastian Fuchs; Anne Rensing-Ehl; Ulrich Pannicke; Myriam R Lorenz; Paul Fisch; Yogesh Jeelall; Jan Rohr; Carsten Speckmann; Thomas Vraetz; Susan Farmand; Annette Schmitt-Graeff; Marcus Krüger; Brigitte Strahm; Philipp Henneke; Anselm Enders; Keisuke Horikawa; Christopher Goodnow; Klaus Schwarz; Stephan Ehl
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.